Holm; Patrik

Patent Applications and Registrations

Patent applications and USPTO patent grants for Holm; Patrik.The latest application filed is for "androgen receptor modulating compounds".

Company Profile

4.17.22

Holm; Patrik - Lielahti FI
HOLM; Patrik - Lielahti TL FI
Holm; Patrik - Vaasa FI
Holm; Patrik - Pargas FI
Holm; Patrik - Molndal SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Androgen receptor modulating compounds Grant 11,046,713 - Wohlfahrt , et al. June 29, 2	2021-06-29
Androgen Receptor Modulating Compounds App 20200299307 - WOHLFAHRT; Gerd ; et al.	2020-09-24
Androgen receptor modulating compounds Grant 10,711,013 - Wohlfahrt , et al.	2020-07-14
Androgen Receptor Modulating Compounds App 20190100536 - WOHLFAHRT; Gerd ; et al.	2019-04-04
Androgen receptor modulating compounds Grant 10,118,933 - Wohlfahrt , et al. November 6, 2	2018-11-06
Androgen Receptor Modulating Compounds App 20170260206 - WOHLFAHRT; Gerd ; et al.	2017-09-14
Androgen receptor modulating compounds Grant 9,657,003 - Wohlfahrt , et al. May 23, 2	2017-05-23
N-prop-2-ynyl carboxamide derivatives and their use as TRPA1 antagonists Grant 9,533,952 - Arvela , et al. January 3, 2	2017-01-03
N-prop-2-ynyl Carboxamide Derivatives And Their Use As Trpa1 Antagonists App 20150376130 - ARVELA; Riina ; et al.	2015-12-31
Androgen Receptor Modulating Compounds App 20150203479 - WOHLFAHRT; Gerd ; et al.	2015-07-23
Androgen receptor modulating compounds Grant 8,975,254 - Wohlfahrt , et al. March 10, 2	2015-03-10
Wind power station Grant 8,847,422 - Holm September 30, 2	2014-09-30
2,3-dihydrobenzo[1,4] dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases Grant 8,809,536 - Din Belle , et al. August 19, 2	2014-08-19
2,3-dihydrobenzo[1,4] Dioxin-2-ylmethyl Derivatives As Alpha2c Antagonists For Use In The Treatment Of Peripheric And Central Nervous System Diseases App 20140179926 - DIN BELLE; David ; et al.	2014-06-26
2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases Grant 8,697,723 - Din Belle , et al. April 15, 2	2014-04-15
2,3-dihydrobenzo(1,4) Dioxin-2-ylmethyl Derivatives As Alpha2c Antagonists For Use In The Treatment Of Peripheric And Central Nervous System Diseases App 20130281486 - DIN BELLE; David ; et al.	2013-10-24
2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous systeme diseases Grant 8,492,549 - Din Belle , et al. July 23, 2	2013-07-23
Adjustment System For The Pitch Angle Of A Wind Turbine App 20130039762 - EKOLA; Juhani ; et al.	2013-02-14
Wind Power Station App 20120235420 - Holm; Patrik	2012-09-20
Androgen Receptor Modulating Compounds App 20120225867 - Wohlfahrt; Gerd ; et al.	2012-09-06
2,3-dihydrobenzo(1,4) Dioxin-2-ylmethyl Derivatives As Alpha2c Antagonists For Use In The Treatment Of Peripheric And Central Nervous Systeme Diseases App 20120035210 - Din Belle; David ; et al.	2012-02-09
Aryl Piperazine And Their Use As Alpha2c Antagonists App 20110262352 - Din Belle; David ; et al.	2011-10-27
Wind Power Station App 20110156405 - Holm; Patrik	2011-06-30
Non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulators Grant 7,960,380 - Broo , et al. June 14, 2	2011-06-14
Non-Anilinic Derivatives Of Isothiazol-3(2H)-one 1,1-Dioxides As Liver X Receptor Modulators App 20100227847 - Broo; Anders ; et al.	2010-09-09
2,3-dihydrobenzo(1,4) Dioxin-2-ylmethyl Derivatives As Alpha2c Antagonists For Use In The Treatment Of Peripheric And Central Nervous Systeme Diseases App 20100216836 - Din Belle; David ; et al.	2010-08-26
Non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulators Grant 7,723,333 - Broo , et al. May 25, 2	2010-05-25
Derivatives Of Isothiazol-3(2h)-one 1,1-dioxides As Liver X Receptor Modulator App 20100016321 - Bostrom; Jonas ; et al.	2010-01-21
Derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulators Grant 7,582,629 - Bostrom , et al. September 1, 2	2009-09-01
Non-Anilinic Derivatives of Isothiazol-3(2H)-one 1,1-Dioxides as Liver X Receptor Modulators App 20090005353 - Broo; Anders ; et al.	2009-01-01
Derivatives of Isothiazol-3(2H)-One 1,1-Dioxides as Liver X Receptor Modulators App 20080255122 - Bostrom; Jonas ; et al.	2008-10-16
5-Thioxo-1,5-Dihydro-2H-Pyrrol-2-One Derivatives As Liver X Receptor Modulators App 20080255207 - Holm; Patrik ; et al.	2008-10-16
Pyrrole-2,5-dione derivatives as Liver X receptor modulators Grant 7,432,288 - Bostrom , et al. October 7, 2	2008-10-07
Therapeutic agents App 20060199857 - Lindstedt-Alstermark; Eva-Lotte ; et al.	2006-09-07
Pyrrole-2,5-dithione derivatives as liver x receptor modulators App 20060189663 - Holm; Patrik	2006-08-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.